Cidara TherapeuticsCDTX
那斯達克 · USD
62.20
+0.20
(+0.32%)
收盤 08/12 03:57 (UTC+8)
08/12 03:57 (UTC+8)
Cidara TherapeuticsCDTX
62.20
+0.20
(+0.32%)
財務數據
損益表
- 0.10
- 0.26
- 0.07
- 0.09
- 0.03
- 0.08
- 0.00
- -
- -
- -
- -74.92
- 155.48
- -71.15
- 22.94
- -70.10
- 207.08
- -96.43
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | 2023/Q1 | 2022/Q4 | |
營業收入淨額 | - | - | - | 302 | 8,463 | 2,756 | 9,217 | 7,497 | 26,107 | 10,219 |
營業成本 | - | - | - | - | 1,563 | - | - | - | - | - |
營業毛利 | - | - | - | - | 6,900 | 2,756 | 9,217 | 7,497 | 26,107 | 10,219 |
營業費用 | - | - | - | - | 17,591 | - | 13,685 | 20,132 | 23,326 | 23,486 |
研發費用 | 24,600 | 46,874 | 12,429 | 6,657 | 11,593 | 8,010 | 10,386 | 16,981 | 18,869 | 20,058 |
推銷及管理費用 | 669 | 7,308 | 4,965 | 4,746 | 5,998 | 3,447 | 3,299 | 3,151 | 4,457 | 3,428 |
非經常性項目費用 | - | - | - | 84,883 | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -25,269 | -54,182 | -17,394 | -95,984 | -10,691 | -8,701 | -4,468 | -12,635 | 2,781 | -13,267 |
其他收入及費用 | 1,789 | 1,813 | 1,859 | 1,774 | 365 | 527 | 613 | - | 232 | - |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | -23,480 | -52,369 | -15,535 | -94,210 | -10,326 | -8,174 | -3,855 | -12,012 | 3,013 | -13,105 |
所得稅 | - | - | - | - | - | 7 | -32 | - | - | 272 |
稅後純益 | -23,480 | -52,307 | -15,985 | -91,209 | -10,326 | -3,213 | -9,107 | -12,161 | 3,013 | -13,377 |
基本每股稅後盈餘(元) | -1.66 | -5.37 | -2.45 | -19.99 | -0.11 | - | -0.10 | -0.15 | 0.03 | -0.19 |
稀釋每股稅後盈餘(元) | -1.66 | -4.22 | -0.22 | -20.03 | -0.11 | -0.03 | -0.10 | -0.14 | 0.03 | -0.24 |
基本平均股數(千股) | 14177.00 | 9727.00 | 6530.00 | 4563.00 | 90755.00 | - | 90287.00 | 90116.00 | 78640.00 | 71895.00 |
稀釋平均股數(千股) | 14177.00 | 9727.00 | 6530.00 | 4563.00 | 90755.00 | - | 90287.00 | 90116.00 | 101189.00 | 71895.00 |
還原基本每股稅後盈餘(元) | -1.66 | -5.37 | -2.45 | -19.99 | -2.28 | - | -2.02 | -3.02 | 0.60 | -3.80 |
還原稀釋每股稅後盈餘(元) | -1.66 | -4.22 | -0.22 | -20.03 | -2.28 | -0.69 | -2.05 | -2.80 | 0.60 | -4.80 |
還原基本平均股數(千股) | 14,177 | 9,727 | 6,530 | 4,563 | 4,537 | - | 4,514 | 4,505 | 3,932 | 3,594 |
還原稀釋平均股數(千股) | 14,177 | 9,727 | 6,530 | 4,563 | 4,537 | - | 4,514 | 4,505 | 5,059 | 3,594 |
EBITDA(千元) | -23,431 | -52,248 | -15,924 | -90,984 | -10,254 | -3,143 | -9,104 | -12,571 | 3,520 | -13,766 |